Effect of melatonin receptor agonist(ramelteon) for sleep disorder with type 2 diabetes mellitus

Effect of melatonin receptor agonist(ramelteon) for sleep disorder with type 2 diabetes mellitus - Effect of ramelteon for sleep disorder with diabetes

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012271

Enrollment

100

Registered

2013-11-15

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes mellitus with sleep disorder

Interventions

Ramelteon 8mg/day Lifestyle instruction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who give informed consent

Exclusion criteria

Exclusion criteria: Patients who has contraindication with Ramelteon Patients who judged as ineligible by clinical investigators

Design outcomes

Primary

Measure	Time frame
Changes of HbA1c and contents of sleep	—

Countries

Japan

Contacts

Public ContactSatoshi Ito

Machida Municipal Hospital Endocrine/diabetes

s.itou@machida-city-hp.jp0427-22-2230

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026